CNMD
CONMED Corporation
45.20$
-1.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +22.3% | -48.4% | +48.7% | +18.2% | -15.4% | -4.2% | -29.9% | +84.3% | -13.7% | -70.9% | +175.3% | – | |
| – | +0.7% | +0.2% | -1.1% | -27.2% | +38.6% | +1.4% | +1.7% | +0.2% | +1.3% | -77.9% | -2.3% | – | |
| – | -4.3% | +5.4% | +11.8% | -12.2% | +1.6% | +122.8% | -64.6% | -6.5% | +8.4% | +10.7% | -4.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +212.1% | -304.2% | – | – | -240.1% | – | -2,835.4% | – | -175.1% | – | – | – | |
| – | -10.0% | -58.1% | +76.4% | -4.8% | +18.2% | -6.5% | +51.6% | -9.5% | -1.5% | -43.4% | +1.5% | – | |
| – | -10.0% | -58.1% | +76.4% | -4.8% | +18.2% | -27.5% | +95.6% | -9.5% | +37.1% | – | +181.5% | – | |
| – | +0.1% | +0.1% | +0.1% | +0.1% | +0.2% | +0.0% | +0.1% | +0.0% | +0.0% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -83.2% | – | |
| – | – | – | – | – | +38.5% | -59.5% | -24.6% | +163.7% | -31.0% | – | -176.7% | – | |
| – | +57.9% | -71.0% | +159.1% | -11.9% | +31.5% | -44.4% | -6.6% | +64.1% | -14.1% | -39.6% | +105.0% | – | |
| – | -333.8% | – | -152.2% | – | -245.9% | – | -114.1% | – | -62.2% | -406.5% | – | – | |
| – | +26.5% | -47.4% | +46.6% | +20.3% | -17.8% | -3.9% | -38.0% | +107.2% | -15.0% | -74.3% | +222.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.